AI chatbot
A study published in The American Journal of Gastroenterology found two versions of ChatGPT flunked tests gauged to determine if one would pass an actual board exam.
According to a research letter published in JAMA, the AI chatbot provided appropriate answers for 21 of 25 questions.
However, these tools are not yet able to provide personalised advice.
Ramakant Vempati, Wysa cofounder and president, discusses how the startup tests its AI-backed chatbot to monitor safety and quality.
The startup announced a $5.5 million Series A raise in May 2021.
This additional funding brings the company's total Series B raise to $120 million.
The company says that the chatbot combines AI with the type of healthcare that regards a patient's customs and beliefs.
New data published in JMIR outlines encouraging results from a modified version of the text-based chatbot app.
The new funds will be put towards expanding into Indonesia, Philippines, Malaysia and India.
The New York-based company also announced the launch of a pediatric care offering for children ages 3-17.